ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
-8.36%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$321M
AUM Growth
+$321M
(-4.3%)
Cap. Flow
+$14.4M
Cap. Flow
% of AUM
4.47%
Top 10 Holdings %
Top 10 Hldgs %
44.07%
Holding
97
New
19
Increased
18
Reduced
17
Closed
33
Top Buys
| 1 |
Establishment Labs
ESTA
|
$8.02M |
| 2 |
Biohaven
BHVN
|
$6.54M |
| 3 |
argenx
ARGX
|
$6.15M |
| 4 |
RxSight
RXST
|
$5.95M |
| 5 |
ResMed
RMD
|
$5.95M |
Top Sells
| 1 |
Vera Therapeutics
VERA
|
$10.7M |
| 2 |
Vaxcyte
PCVX
|
$8.23M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$6.6M |
| 4 |
iRhythm Technologies
IRTC
|
$6.38M |
| 5 |
Glaukos
GKOS
|
$5.55M |
Sector Composition
| 1 | Healthcare | 99.91% |
| 2 | Consumer Staples | 0.09% |
| 3 | Consumer Discretionary | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Syndax Pharmaceuticals
SNDX
$1.39B
| $4.89M | 1.39% |
+370,000
| New | +$4.89M |
|
27
Savara
SVRA
$591M
| $4.85M | 1.37% |
1,579,000
+4,000
| +0.3% | +$12.3K |
|
|
AVDL
28
Avadel Pharmaceuticals
AVDL
$1.42B
| $4.76M | 1.35% |
452,475
-157,525
| -26% | -$1.66M |
|
29
Corbus Pharmaceuticals
CRBP
$121M
| $4.54M | 1.29% |
385,000
+190,000
| +97% | +$2.24M |
|
30
Arrowhead Research
ARWR
$3.84B
| $4.33M | 1.23% |
230,257
-124,743
| -35% | -$2.35M |
|
|
AVR
31
Anteris Technologies Global Corp. Common Stock
AVR
$148M
| $4.11M | 1.17% |
+737,000
| New | +$4.11M |
|
|
PROF
32
Profound Medical
PROF
$131M
| $3.64M | 1.03% |
+485,000
| New | +$3.64M |
|
33
Xtant Medical Holdings
XTNT
$82.4M
| $3.29M | 0.93% |
7,415,413
| – | – |
|
34
Skye Bioscience
SKYE
$104M
| $3.22M | 0.91% |
1,139,000
-176,146
| -13% | -$498K |
|
35
Oric Pharmaceuticals
ORIC
$1.03B
| $2.86M | 0.81% |
355,000
| – | – |
|
36
TG Therapeutics
TGTX
$5.03B
| $2.86M | 0.81% |
+95,000
| New | +$2.86M |
|
37
Nektar Therapeutics
NKTR
$543M
| $2.79M | 0.79% |
3,000,000
+2,988,581
| +26,172% | +$2.78M |
|
38
Keros Therapeutics
KROS
$640M
| $2.77M | 0.79% |
175,000
+106,000
| +154% | +$1.68M |
|
39
ImmunityBio
IBRX
$2.24B
| $2.71M | 0.77% |
+1,060,000
| New | +$2.71M |
|
40
Lexeo Therapeutics
LXEO
$266M
| $2.66M | 0.76% |
+405,000
| New | +$2.66M |
|
41
Terns Pharmaceuticals
TERN
$651M
| $2.63M | 0.75% |
475,000
+145,000
| +44% | +$803K |
|
42
Revolution Medicines
RVMD
$7.43B
| $2.62M | 0.74% |
+60,000
| New | +$2.62M |
|
43
ESSA Pharma
EPIX
$11.2M
| $2.56M | 0.73% |
+1,428,000
| New | +$2.56M |
|
44
Alphatec Holdings
ATEC
$2.35B
| $2.43M | 0.69% |
+264,562
| New | +$2.43M |
|
45
Larimar Therapeutics
LRMR
$337M
| $1.95M | 0.55% |
505,000
-188,000
| -27% | -$728K |
|
|
OKUR
46
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
| $1.88M | 0.53% |
+218,386
| New | +$1.88M |
|
|
ACOG
47
Alpha Cognition Inc. Common Stock
ACOG
$132M
| $1.62M | 0.46% |
+275,000
| New | +$1.62M |
|
48
ProQR Therapeutics
PRQR
$256M
| $1.52M | 0.43% |
+575,000
| New | +$1.52M |
|
49
Veru
VERU
$48.5M
| $1.32M | 0.37% |
2,028,534
| – | – |
|
50
Unicycive Therapeutics
UNCY
$75.8M
| $1.17M | 0.33% |
1,473,000
| – | – |
|